Terms: = Gastric cancer AND RHOH, TTF, 399, ENSG00000168421, ARHH, RhoH
203 results:
1. Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study.
Holmberg D; Kauppila JH; Asplund J; Leijonmarck W; Mattsson F; Lagergren J
Gastric Cancer; 2024 May; 27(3):590-597. PubMed ID: 38430275
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study.
Li N; Li Z; Fu Q; Zhang B; Zhang J; Wan XB; Lu CM; Wang JB; Deng WY; Ma YJ; Bie LY; Wang MY; Li J; Xia QX; Wei C; Luo SX
Int J Surg; 2024 Apr; 110(4):2071-2084. PubMed ID: 38320099
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Shitara K; Rha SY; Wyrwicz LS; Oshima T; Karaseva N; Osipov M; Yasui H; Yabusaki H; Afanasyev S; Park YK; Al-Batran SE; Yoshikawa T; Yanez P; Dib Bartolomeo M; Lonardi S; Tabernero J; Van Cutsem E; Janjigian YY; Oh DY; Xu J; Fang X; Shih CS; Bhagia P; Bang YJ;
Lancet Oncol; 2024 Feb; 25(2):212-224. PubMed ID: 38134948
[TBL] [Abstract] [Full Text] [Related]
4. The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
Zhao L; Zhang F; Jiao F; Zhou X; Niu P; Han X; Wang W; Luan X; He M; Guan Q; Li Y; Zhao D; Gao J; Chen Y
BMC Cancer; 2023 Sep; 23(1):892. PubMed ID: 37735628
[TBL] [Abstract] [Full Text] [Related]
5. Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.
Nishikawa K; Kawakami H; Shimokawa T; Fujitani K; Tamura S; Endo S; Kobayashi M; Kawada J; Kurokawa Y; Tsuburaya A; Yoshikawa T; Sakamoto J; Satoh T;
Int J Clin Oncol; 2023 Nov; 28(11):1501-1510. PubMed ID: 37634209
[TBL] [Abstract] [Full Text] [Related]
6. Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study.
Kawabata R; Chin K; Takahari D; Hosaka H; Muto O; Shindo Y; Nagata N; Yabusaki H; Imamura H; Endo S; Kashiwada T; Nakamura M; Hihara J; Kobayashi M; Sagawa T; Saito S; Sato A; Yamada T; Okano N; Shimada K; Matsushima M; Kataoka M; Matsumoto S; Goto M; Kotaka M; Shiraishi T; Yamai H; Nagashima F; Ishizuka N; Yamaguchi K
Gastric Cancer; 2023 Nov; 26(6):1020-1029. PubMed ID: 37610558
[TBL] [Abstract] [Full Text] [Related]
7. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
8. Using Normalized Carcinoembryonic Antigen and Carbohydrate Antigen 19 to Predict and Monitor the Efficacy of Neoadjuvant Chemotherapy in Locally Advanced gastric cancer.
Tang XH; Wu XL; Gan XJ; Wang YD; Jia FZ; Wang YX; Zhang Y; Gao XY; Li ZY
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569566
[TBL] [Abstract] [Full Text] [Related]
9. Interaction between Age and Primary Site on Survival Outcomes in Primary GI Melanoma over the Past Decade.
Bangolo A; Fwelo P; Sagireddy S; Shah H; Trivedi C; Bukasa-Kakamba J; Patel R; Bharane L; Randhawa MK; Nagesh VK; Dey S; Terefe H; Kaur G; Dinko N; Emiroglu FL; Mohamed A; Fallorina MA; Kosoy D; Waqar D; Shenoy A; Ahmed K; Nanavati A; Singh A; Willie A; Gonzalez DMC; Mukherjee D; Sajja J; Proverbs-Singh T; Elias S; Weissman S
Med Sci (Basel); 2023 Apr; 11(2):. PubMed ID: 37218984
[TBL] [Abstract] [Full Text] [Related]
10. The clinical impacts of postoperative complications after colon cancer surgery for the clinical course of adjuvant treatment and survival.
Aoyama T; Oba K; Honda M; Muto M; Mayanagi S; Maeda H; Kanda M; Kashiwabara K; Sakamoto J; Yoshikawa T
Int J Clin Oncol; 2023 Jun; 28(6):777-784. PubMed ID: 37039949
[TBL] [Abstract] [Full Text] [Related]
11. Medium and large alleles of the PGC gene are risk factors for gastric cancer.
Sánchez-López JY; Vázquez-Ibarra KC; García-Muro AM; García-Ruvalcaba A; Pacheco-Sotelo S; Díaz-Herrera LC; Marin-Contreras ME
Tumour Biol; 2023; 45(1):15-21. PubMed ID: 37038800
[TBL] [Abstract] [Full Text] [Related]
12. Morphometric features of gastric mucosa in atrophic gastritis: A different pattern between corpus and antrum.
Lin XM; Wang L; Xi CH; Wang J; Wang XF; Wang Q; Yuan C
Medicine (Baltimore); 2023 Apr; 102(14):e33480. PubMed ID: 37026936
[TBL] [Abstract] [Full Text] [Related]
13. Clinical Evaluation of Computer-Aided Colorectal Neoplasia Detection Using a Novel Endoscopic Artificial Intelligence: A Single-Center Randomized Controlled Trial.
Nakashima H; Kitazawa N; Fukuyama C; Kawachi H; Kawahira H; Momma K; Sakaki N
Digestion; 2023; 104(3):193-201. PubMed ID: 36599306
[TBL] [Abstract] [Full Text] [Related]
14. The Impact of Nutritional Support on Survival Outcomes in Patients with Advanced gastric Adenocarcinoma Treated with Chemotherapy.
Sugiyama K; Shiraishi K; Motohashi T; Onoda S; Sato M; Kato K; Uda H; Hattori M; Suenaga M; Hirashima N; Shimada M; Kataoka M; Kitagawa C
Nutr Cancer; 2023; 75(3):867-875. PubMed ID: 36591915
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/ttf-1) in gastric adenocarcinoma of fundic-gland type.
Fukagawa K; Takahashi Y; Yamamichi N; Kageyama-Yahara N; Sakaguchi Y; Obata M; Cho R; Sakuma N; Nagao S; Miura Y; Tamura N; Ohki D; Mizutani H; Yakabi S; Minatsuki C; Niimi K; Tsuji Y; Yamamichi M; Shigi N; Tomida S; Abe H; Ushiku T; Koike K; Fujishiro M
Gastric Cancer; 2023 Jan; 26(1):44-54. PubMed ID: 36094595
[TBL] [Abstract] [Full Text] [Related]
16. Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Rosery V; Mika S; Schmid KW; Reis H; Stuschke M; Treckmann J; Markus P; Schumacher B; Albers D; Mende B; Lahner H; Wiesweg M; Schuler M; Siveke JT; Kasper S
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4315-4325. PubMed ID: 36071236
[TBL] [Abstract] [Full Text] [Related]
17. Association Between Peripheral Neuropathy Induced by Oxaliplatin at First-line Chemotherapy and Efficacy of Paclitaxel at Second-line Chemotherapy in Patients With Advanced gastric cancer.
Fujii H; Sadaka S; Ajisawa K; Okumura N; Makiyama A; Iihara H; Yasufuku I; Ohata K; Kobayashi R; Tanaka Y; Hayashi H; Suzuki A
Anticancer Res; 2022 Sep; 42(9):4581-4588. PubMed ID: 36039452
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy Evaluation of 64-Slice Spiral Computed Tomography Images in Laparoscopic-Assisted Distal Gastrectomy for gastric cancer under the Reconstruction Algorithm.
Yu W; Li X; Zhou H; Zhang Y; Sun Z
Contrast Media Mol Imaging; 2022; 2022():2464640. PubMed ID: 36017021
[TBL] [Abstract] [Full Text] [Related]
19. [Influence of visceral lipids obesity on the early postoperative complications after radical gastrectomy].
Qiu GL; Li XW; Wang HJ; Wang PX; Liu JH; Zhu MK; Liao XH; Fan L; Che XM
Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):596-603. PubMed ID: 35844122
[No Abstract] [Full Text] [Related]
20. Functional genomics screening identifies aspartyl-tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers.
Liu B; Katoh H; Komura D; Yamamoto A; Ochi M; Onoyama T; Abe H; Ushiku T; Seto Y; Suo J; Ishikawa S
J Pathol; 2022 Oct; 258(2):106-120. PubMed ID: 35696251
[TBL] [Abstract] [Full Text] [Related]
[Next]
